Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Cullen
FOU | Founder | 78 | 11-09-20 |
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 20-07-15 |
Susan Horvath
DFI | Director of Finance/CFO | 65 | 18-04-16 |
Tammy Groene
COO | Chief Operating Officer | - | 12-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 | |
Rachel Bragg
PRN | Corporate Officer/Principal | - | 21-05-31 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 20-07-15 |
Director/Board Member | 63 | 15-09-29 | |
Michael Cullen
FOU | Founder | 78 | 11-09-20 |
Jeffrey Jacob
BRD | Director/Board Member | 62 | 22-06-14 |
Arthur Fratamico
BRD | Director/Board Member | 58 | 19-12-15 |
Dan Donovan
BRD | Director/Board Member | 59 | 22-06-14 |
Donald Schemel
BRD | Director/Board Member | 68 | 15-09-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,854,931 | 4,854,791 ( 100.00 %) | 70 ( 0.001442 %) | 100.00 % |
Company contact information
Panbela Therapeutics, Inc.
712 Vista Boulevard Suite 305
55387, Waconia
+952 479 1196
http://www.panbela.com1st Jan change | Capi. | |
---|---|---|
+14.25% | 3,161B | |
+11.02% | 87.62B | |
+6.56% | 79.59B | |
-12.92% | 54.14B | |
+23.73% | 48.15B | |
+32.42% | 47.69B | |
-24.91% | 46.81B | |
+81.14% | 42B | |
-6.15% | 25.77B |